In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts compare the toxicities of immunotherapy versus chemotherapy and the timeline for these toxicities to the skin, gastrointestinal, hepatic, renal, pulmonary and endocrine systems and recommend appropriate follow-up for patients with immune-related adverse effects from endocrine systems.
HOST
Jessie Hipple Rosario, PharmD, MMHC, serves as a Director of Member Relations and the liaison to the Section of Specialty Pharmacy Practitioners at ASHP. In this role, Dr. Hipple Rosario serves as the secretary for the Section Executive Committee and leads the development and implementation of strategies and programs to accomplish the objectives established by the Section.
Prior to this role, Dr. Hipple Rosario completed the ASHP Executive Fellowship in Association Leadership and Management under mentorship from ASHP’s Senior Leadership. Dr. Hipple Rosario received her Doctor of Pharmacy along with a Master of Management in Health Care degree from Lipscomb University College of Pharmacy and Health Sciences prior to completing an ASHP accredited PGY1 pharmacy residency at Maury Regional Medical Center in Tennessee. She previously obtained a Bachelor of Science in Toxicology from The Pennsylvania State University.